Die Liste ist nach Jahreszahlen geordnet, darunter alphabetisch nach den Erstautoren.
2016
Akoudad,S., Aarts, N., Noordam, R., Ikram, M. A., Tiemeier, H., Hofman, A., Stricker, B. H., Vernooij, M. W., Visser, L. E.(2016): Antidepressant Use Is Associated With an Increased Risk of Developing Microbleeds. Stroke 47: 251-254
doi: 10.1161/STROKEAHA.115.011574 http://stroke.ahajournals.org/content/4 ... fc612c61ac
Breggin, PR. (2016): Rational Principles of Psychopharmacology for Therapists, Healthcare Providers and Clients. J Contemp Psychother 46:1–13. http://breggin.com/index.php?option=com ... &Itemid=37
Lucire, Y. (2016): Pharmacological Iatrogenesis: Substance/Medication-Induced Disorders That Masquerade as Mental Illness. Epidemiology (sunnyvale) 6:1 http://dx.doi.org/10.4172/2161-1165.1000217
Satoshi Ueda, Takeshi Sakayori, Ataru Omori, Hajime Fukuta, Takashi Kobayashi, Kousuke Ishizaka, Tomoyuki Saijo, Yoshiro Okubo (2016): Neuroleptic-induced deficit syndrome in bipolar disorder with psychosis Neuropsychiatr Dis Treat. 2016; 12: 265–268. doi: 10.2147/NDT.S99577
PMCID: PMC4745952 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745952/
Sharma, T., Schow Guski, L., Freund, N., Gøtzsche, P. C. (2016): Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports British Medical Journal 352:i65 doi: http://dx.doi.org/10.1136/bmj.i65 http://www.bmj.com/content/352/bmj.i65.full.pdf+html
Uher, R., Pavlova, B. (2016): Long-term effects of depression treatment. The Lancet Psychiatry 3 (2): 95 - 96 http://dx.doi.org/10.1016/S2215-0366(15)00578-7 http://www.thelancet.com/pdfs/journals/ ... 0578-7.pdf
2015
Amerio, A., Gálvez, J. F. Odone, A., Dalley, S. A., Ghaemi, S. N. (2015): Carcinogenicity of psychotropic drugs: A systematic review of US Food and Drug Administration–required preclinical in vivo studies. Australian & New Zealand Journal of Psychiatry 49(8): 686–696 DOI: 10.1177/0004867415582231 http://anp.sagepub.com/content/49/8/686.full.pdf+htmlAndrews, P. W., Bharwania, A., Leea, K. R., Fox, M., Anderson Thomson, J., Jr. (2015): Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response. Neuroscience & Biobehavioral Reviews 51: 164–188
doi:10.1016/j.neubiorev.2015.01.018 http://www.sciencedirect.com/science/ar ... 3415000287
Chouinard, G., Chouinard, V. (2015): New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal. Psychother Psychosom 84:63-71. DOI:10.1159/000371865 http://www.karger.com/Article/Pdf/371865
Cressman, A. M., Macdonald, E. M., Huang, A., Gomes, T., Paterson, M., Kurdyak, P. A., Mamdani, M. M., Juurlink, D. N.
(2015): Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study. Journal of Clinical Psychopharmacology 35(6): 667–671 doi: 10.1097/JCP.0000000000000406 http://journals.lww.com/psychopharmacol ... for.8.aspx
Fava, G.A., Guidi, J., Rafanelli, C., Sonino, N. (2015): The Clinical Inadequacy of Evidence-Based Medicine and the Need for a Conceptual Framework Based on Clinical Judgment. Psychother Psychosom 84:1-3 DOI:10.1159/000366041 http://www.karger.com/Article/Pdf/366041
Lacasse, J. R., Leo, J. (2015): Antidepressants and the Chemical Imbalance Theory of Depression: A Reflection and Update on the Discourse. The Behavior Therapist 38(7): 206-213. https://www.researchgate.net/publicatio ... _Discourse
Le Noury, J., Nardo, J. M., Healy, D., Jureidini, J., Raven, M., Tufanaru, C., Abi-Jaoude, E. (2015): Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence BMJ 2015;351:h4320 doi:10.1136/bmj.h4320 http://study329.org/wp-content/uploads/ ... -Final.pdf
Moncrieff, J. (2015): Antidepressants: misnamed and misrepresented. World Psychiatry 14(3): 302–303 DOI: 10.1002/wps.20243 http://onlinelibrary.wiley.com/doi/10.1 ... 20243/epdf
Takayanagi, Y., Spira, A.P., Bienvenu, O.J., Hock, R.S., Carras, M.C., Eaton, W.W., Mojtabai, R. (2015): Antidepressant use and lifetime history of mental disorders in a community sample: results from the Baltimore Epidemiologic Catchment Area Study. J Clin Psychiatry 76(1):40-4
doi: 10.4088/JCP.13m08824 http://www.ncbi.nlm.nih.gov/pmc/article ... 695626.pdf
2014
Breggin, P. R. (2014): The Rights of Children and Parents In Regard to Children Receiving Psychiatric Diagnoses and Drugs. Children & Society, 28, (2014) pp. 231-241 http://breggin.com/index.php?option=com ... &Itemid=37Maund, E., Tendal, B.,Hróbjartsson, A.,Jørgensen, K. J., Lundh, A., Schroll, J., Gøtzsche, P. C. (2014): Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications BMJ 2014; 348 doi: http://dx.doi.org/10.1136/bmj.g3510 http://www.bmj.com/content/bmj/348/bmj.g3510.full.pdf
Moncrieff, J. (2014): The Nature of Mental Disorder: Disease, Distress, or Personal Tendency? Philosophy, Psychiatry, & Psychology 21;3: 257-260 http://muse.jhu.edu/journals/philosophy ... rieff.html
Read, J., Cartwright, C., Gibson, K. (2014): Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants. Psychiatry Res. 30;216(1):67-73 doi: 10.1016/j.psychres.2014.01.042 http://www.ncbi.nlm.nih.gov/pubmed/24534123
Thomas, . H., Martin, R. M., Potokar, J., Pirmohamed, M., Gunnell, D. (2014): Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011. BMC Pharmacol Toxicol.15: 54. doi: 10.1186/2050-6511-15-54 PMCID: PMC4184159 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184159/
2013
Nielsen, M., Hansen, E.H., Gøtzsche P.C.(2013): Dependence and withdrawal reactions to benzodiazepines and selective serotonin reuptake inhibitors. How did the health authorities react? GInt J Risk Saf Med 25(3):155-68. doi: 10.3233/JRS-130594. http://www.ncbi.nlm.nih.gov/pubmed/24047687Prousky, J. E. (2013): Tapering Off Psychotropic Drugs: Using Patient Cases to Understand Reasons for Success and Failure. Journal of Orthomolecular Medicine 28:4 159-174 http://www.jonathanprouskynd.com/upload ... ailure.pdf
Renoir, T. (2013): Selective Serotonin Reuptake Inhibitor Antidepressant Treatment Discontinuation Syndrome: A Review of the Clinical Evidence and the Possible Mechanisms Involved. Front Pharmacol 4: 45 doi: 10.3389/fphar.2013.00045 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627130/
2012
Antonuccio,D., Healy, D, (2012): Relabeling the Medications We Call Antidepressants. Scientifica, vol. 2012, Article ID 965908, 6 pages. doi:10.6064/2012/965908 http://www.hindawi.com/journals/scienti ... 65908/cta/Breggin, P. R. (2012): Psychiatric drug-induced Chronic Brain Impairment (CBI): Implications for longterm treatment with psychiatric medication International Journal of Risk & Safety in Medicine 23: 193-200. http://breggin.com/index.php%3Foption%3 ... temid%3D37
Nielsen, M., Hansen, E.H., Gøtzsche, P.C. (2012): What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors. Addiction 107(5):900-8. doi: 10.1111/j.1360-0443.2011.03686.x. http://www.ncbi.nlm.nih.gov/pubmed/21992148
2011
Andrews, P. W., Kornstein, S., G., Halberstadt, L. J., Gardner, C. O., Neale, M. C.(2011): Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression Front Psychol 2: 159. doi: 10.3389/fpsyg.2011.00159 http://www.ncbi.nlm.nih.gov/pmc/article ... -00159.pdfAndrews, P.W., Thomson, J.A., Amstadter, A., Neale, M.C. (2011): Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good Front Psychol. 24;3:117. doi: 10.3389/fpsyg.2012.00117 http://www.ncbi.nlm.nih.gov/pmc/article ... -00117.pdf
El-Mallakh, R. S., Gao, Y., Jeannie Roberts, R. (2011): Tardive dysphoria: the role of long term antidepressant use in-inducing chronic depression Med Hypotheses 76(6):769-73 doi: 10.1016/j.mehy.2011.01.020 http://www.ncbi.nlm.nih.gov/pubmed/21459521
Fava, G.A., Offidani E. (2011): The mechanisms of tolerance in antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry. 5;35(7):1593-602. doi: 10.1016/j.pnpbp.2010.07.026 http://www.ncbi.nlm.nih.gov/pubmed/20728491
Furukawa, T.A. (2011): Rapid discontinuation of antidepressants reduces time to recurrence of depression and panic
Evid Based Mental Health 14:13 doi:10.1136/ebmh1131 http://ebmh.bmj.com/content/14/1/13.extract
Goldsmith, L., Moncrieff, J. (2011): The Psychoactive Effects of Antidepressants and their Association with Suicidality. Current Drug Safety Vol 6(2): 115-121(7) https://joannamoncrieff.files.wordpress ... ds0311.pdf
Middleton, H., Moncrief, J. (2011): 'They won't do any harm and might do some good': Time to think again on the use of antidepressants? British Journal of General Practice 61:47–49 DOI:10.3399/bjgp11X548983 http://www.ncbi.nlm.nih.gov/pmc/article ... 61-047.pdf
Nielsen M., Gøtzsche P. (2011): An analysis of psychotropic drug sales. Increasing sales of selective serotonin reuptake inhibitors are closely related to number of products Int J Risk Saf Med. 23(2):125-32. doi: 10.3233/JRS-2011-0526 http://www.ncbi.nlm.nih.gov/pubmed/21673422
Narayan, V., Haddad, P.M. (2011): Antidepressant discontinuation manic states: a critical review of the literature and suggested diagnostic criteria.
J Psychopharmacol. 25(3):306-13. http://www.ncbi.nlm.nih.gov/pubmed/20156925
van Donkelaar, E. L., Blokland, A., Ferrington, L., Kelly, P.A.T., Steinbusch, H.W.M., Prickaerts, J. (2011): Mechanism of acute tryptophan depletion: is it only serotonin? Molecular Psychiatry 16, 695–713 http://www.nature.com/mp/journal/v16/n7 ... 20119a.pdf
2010
Baldessarini, R.J., Tondo, L., Ghiani, C., Lepri, B. (2010): Illness risk following rapid versus gradual discontinuation of antidepressants. Am J Psychiatry 167(8):934-41. doi: 10.1176/appi.ajp.2010.09060880 http://ajp.psychiatryonline.org/doi/abs ... b%3DpubmedHowland, R.H. (2010): Potential adverse effects of discontinuing psychotropic drugs. Part 1: Adrenergic, cholinergic, and histamine drugs.J Psychosoc Nurs Ment Health Serv. 2010 Jun;48(6):11-4. http://www.mediafire.com/download/uuwnd ... nergic.pdf
Howland, R.H. (2010): Potential adverse effects of discontinuing psychotropic drugs. Part 2: antidepressant drugs. J Psychosoc Nurs Ment Health Serv. 2010 Jul;48(7):9-12. doi: 10.3928/02793695-20100527-98. http://www.mediafire.com/download/0572r ... ssants.pdf
Howland, R.H. (2010): Potential adverse effects of discontinuing psychotropic drugs. Part 3: Antipsychotic, dopaminergic, and mood-stabilizing drugs. J Psychosoc Nurs Ment Health Serv. 2010 Aug;48(8):11-4. http://www.mediafire.com/download/xsv6w ... chotic.pdf
Howland, R.H. (2010): Potential adverse effects of discontinuing psychotropic drugs. Part 4: Part 4: Benzodiazepine, Glutamate, Opioid, and Stimulant Drugs. J Psychosoc Nurs Ment Health Serv. 2010 Sep;48(9):11-4. doi: 10.3928/02793695-20100730-04. Epub 2010 Aug 23. http://www.mediafire.com/download/1akzt ... benzos.pdf
Sansone, R.A., Sansone, L.A., (2010): SSRI-Induced Indifference. Psychiatry (Edgemont) 7(10):14–18 http://www.ncbi.nlm.nih.gov/pmc/article ... _10_14.pdf
2006
Moncrieff, J.(2006): Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem. Medical Hypotheses 67, 517-523 http://psychrights.org/Articles/Moncrie ... rugred.pdfMoncrieff, J., Cohen, D. (2006): Do Antidepressants Cure or Create Abnormal Brain States? PLoS Med 3(7): e240 DOI: 10.1371/journal.pmed.0030240 http://www.plosmedicine.org/article/fet ... tation=PDF
Shelton, R.C. (2006): The nature of the discontinuation syndrome associated with antidepressant drugs. J Clin Psychiatry. 2006;67 Suppl 4:3-7. http://www.mediafire.com/download/1ax1a ... helton.pdf
2004
Breggin, P. R. (2004): Suicidality, violence and mania caused by selective serotonin reuptake inhibitor (SSRIs): A review and analysis. International Journal of Risk & Safety in Medicine 16:31–49 http://www.breggin.com/31-49.pdfMeyer, J. H., Wilson, A. A., Sagrati, S., Hussey, D., Carella, A.,Potter, W. Z., Ginovart, N., Spencer, E. P., Cheok, A., Houle, S. (2004): Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography Study Am J Psychiatry 161:826–835 http://ils.unc.edu/bmh/neoref/nrschizop ... mp/352.pdf
2003
Fava, G. A. (2003): Can Long-Term Treatment With Antidepressant Drugs Worsen the Course of Depression? J Clin Psychiatry 64:123–133 http://www.madinamerica.com/wp-content/ ... ession.pdf2002
Shipko, S. (2002): Serotonin Reuptake Inhibitor Withdrawal: Out of the Frying Pan and Into the Fire. Ethical Human Sciences and Services 4(2):83 - 91 https://www.researchgate.net/publicatio ... o_the_Fire2001
Schweitzer, I., Maguire,K. (2001): Stopping antidepressants. Aust Prescr 2001;24:13-5 http://dx.doi.org/10.18773/austprescr.2001.0082000
van Weel-Baumgarten, E.M., van den Bosch, W.J., Hekster, Y.A., van den Hoogen, H.J., Zitman, F.G. (2000): Treatment of depression related to recurrence: 10-year follow-up in general practice J Clin Pharm Ther 25(1):61-6 http://www.ncbi.nlm.nih.gov/pubmed/107714651998
Goldberg, D., Privett, M., Ustun, B., Simon, G., Linden, M. (1998): The effects of detection and treatment on the outcome of major depression in primary care: a naturalistic study in 15 cities.Br J Gen Pract. 48(437): 1840–1844 http://www.ncbi.nlm.nih.gov/pmc/article ... 198504.pdfTranter, R.; Healy, D. (1998): “Neuroleptic Discontinuation Syndromes.” Journal of Psychopharmacology 12 (4): 401-06. DOI: 10.1177/026988119801200412 https://www.google.de/url?sa=t&rct=j&q= ... 6328,d.ZGg
1994
Lewander T. (1994): Neuroleptics and the neuroleptic-induced deficit syndrome. Acta Psychiatr Scand Suppl. 380:8-13. http://www.ncbi.nlm.nih.gov/pubmed/79140561991
Hoehn-Saric, R; Harris, GJ; Pearlson, GD; Cox, CS; Machlin, SR; Camargo, EE. (1991): A Fluoxetin-Induced Frontal Lobe Syndrome in an Obsessive Compulsive Patient. Journal of Clinical Psychiatry 52 (3): 131-3 http://www.ncbi.nlm.nih.gov/pubmed/20050771989
Baker, G.B.; Greenshaw, A.J. (1989): Effects of Long-Term Administration of Antidepressants and Neuroleptics on Receptors inthe Central Nervous System. Cellular and Molecular Neurobiology. 1989 (vol 9, no1): 1-44. http://www.ncbi.nlm.nih.gov/pubmed/2565769
1980
Hodding, G. C., Jann, M., and Ackerman, I. P. (1980): Drug Withdrawal Syndromes A Literature Review. West J Med. 1980 Nov; 133(5): 383–391.PMCID: PMC1272349 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1272349/